系统性硬化症相关肺动脉高压的治疗进展
@article{LCBL41299,
author = {轩池 朱 和 秀梅 刘},
title = {系统性硬化症相关肺动脉高压的治疗进展},
journal = {临床与病理杂志},
volume = {41},
number = {7},
year = {2020},
keywords = {},
abstract = {肺动脉高压(pulmonary arterial hypertension,PAH)是系统性硬化症(systemic sclerosis,SSc)肺部受累最常见的并发症之一,也是SSc患者最主要的死亡原因。近年来,随着各种新型靶向药物的应用以及治疗策略的改进,系统性硬化症相关肺动脉高压(systemic sclerosis-associated pulmonary arterial hypertension,SSc-PAH)患者的生存率有了明显的提升。},
url = {https://lcbl.amegroups.com/article/view/41299}
}